Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations
- PMID: 16972715
- DOI: 10.1002/bimj.200510231
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations
Abstract
Adaptive seamless phase II/III designs combine a phase II and a phase III study into one single confirmatory clinical trial. Several examples of such designs are presented, where the primary endpoint is binary, time-to-event or continuous. The interim adaptations considered include the selection of treatments and the selection of hypotheses related to a pre-specified subgroup of patients. Practical aspects concerning the planning and implementation of adaptive seamless confirmatory studies are also discussed.
Comment in
-
How practical are adaptive designs likely to be for confirmatory trials?Biom J. 2006 Aug;48(4):644-9; discussion 660-2. doi: 10.1002/bimj.200610242. Biom J. 2006. PMID: 16972716
-
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations.Biom J. 2006 Aug;48(4):650-5; discussion 660-2. doi: 10.1002/bimj.200610248. Biom J. 2006. PMID: 16972717
-
Plan to be flexible: a commentary on adaptive designs.Biom J. 2006 Aug;48(4):656-9; discussion 660-2. doi: 10.1002/bimj.200610241. Biom J. 2006. PMID: 16972718
MeSH terms
LinkOut - more resources
Full Text Sources